You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 上海凱寶漲7% 公司產品痰熱清膠囊入選新冠病毒感染者居家中醫藥干預指引
格隆匯 12-13 10:03
格隆匯12月13日丨上海凱寶(30039.SZ)漲7.62%,報11.3元,總市值118億元,自上週三(12月7日)以來漲逾67%。上海凱寶12日披露股票交易異動公吿,近日,公司產品痰熱清膠囊入選國家中醫藥管理局發佈的《新冠病毒感染者居家中醫藥干預指引》,被列為成人治療方案推薦用藥。公司產品痰熱清注射液、痰熱清膠囊和熊膽滴丸中均含有原材料熊膽粉,所用熊膽粉來自於原材料供應商。近日,公司關注到“Nature”期刊發表研究論文,顯示熊去氧膽酸可以用於預防新冠感染。該研究目前尚未進行驗證性臨牀試驗,能否用於新冠病毒預防及治療存在較大不確定性,短期內不會對公司的生產經營產生重大影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account